The weight-loss drug revolution

The weight-loss drug revolution

Up next

Small country, auto giant

When Slovakia was part of the Czechoslovak Socialist Republic, the cars it made were noisy, thirsty and slow by western standards at the time. But when Volkswagen bought the car-maker Skoda, that was the beginning of a major change. Now, Slovakia makes almost a million cars a yea ...  Show more

America's affordability question

In the second of two programmes, we look at Donald Trump's record on the economy one year into his second presidential term. Today, we are asking is the United States still facing a cost of living crunch?Its economy - the largest in the world - is still growing faster than most o ...  Show more

Recommended Episodes

The Big Business Behind Weight Loss Drugs
Chasing Life

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs
Motley Fool Money

Weight loss drug sales are estimated to hit $44 billion by 2030. Many of these treatments can thank previously obscure research on a carnivorous deep sea fish for their development. Rolfe Winkler is a reporter for the Wall Street Journal covering digital health. Ricky Mulvey cau ...  Show more

The Ozempic Era of Weight Loss
The Daily

Drugs like Ozempic are revolutionizing the treatment of obesity. The medications, originally used to treat diabetes, keep gaining attention as celebrities and other influencers describe taking them to lose weight quickly.

Dani Blum, a reporter for The Times, tells the st ...

  Show more

Terence Flynn: The Next Blockbuster for Pharma?
Thoughts on the Market

As new weight management medications are being developed, might the obesity market parallel the likes of hypertension or high blood pressure to become the next blockbuster Pharma category?


----- Transcript -----


Welcome to Thoughts on the Mark ...

  Show more